Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Interventional 12 Observational 2 Expanded_access 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Interventions

3-Iodobenzylguanidine 9 Cyclophosphamide 6 Amifampridine 6 nilotinib 5 fludarabine 5 Magnetic Resonance Spectroscopy 5 trametinib 4 pembrolizumab 4 gallium 68 PSMA-11 4 fludarabine phosphate 4 elotuzumab 4 dabrafenib 4 Nivolumab 4 Bortezomib 4 Afatinib 4 venetoclax 3 regorafenib 3 midostaurin 3 TIC10 compound 3 Sunitinib 3 Prednisone 3 Lenalidomide 3 Ipilimumab 3 Everolimus 3 Dexamethasone 3 Crizotinib 3 Capecitabine 3 Axitinib 3 Alpelisib 3 Abiraterone Acetate 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Expanded_access × Antibodies, Bispecific × Clear all

NCT05119257 2024-05-08

InHeAb01

University Hospital Tuebingen

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡